Inventor
DAVIS-SMYTH TERRI LYNN
US9 patents
⚠️ This page may combine multiple inventors who share the name “DAVIS-SMYTH TERRI LYNN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
5 patentsUS6897294B2May 24, 2005
Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
GENENTECH INC171 citations98
US6383486B1May 7, 2002
Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
GENENTECH INC114 citations98
US6100071AAug 8, 2000
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
GENENTECH INC222 citations98
US5952199ASep 14, 1999
Chimeric receptors as inhibitors of vascular endothelial growth factor activity, and processes for their production
GENENTECH INC157 citations98
US7771721B2Aug 10, 2010
Methods for using chimeric vascular endothelial growth factor receptor proteins
GENENTECH INC52 citations97
DAVIS-SMYTH TERRI LYNN
4 patentsUS9273113B2Mar 1, 2016
Methods of inhibiting vascular endothelial growth factor activity
DAVIS-SMYTH TERRI LYNN9 citations91
US8273353B2Sep 25, 2012
Inhibitors of vascular endothelial growth factor activity
DAVIS-SMYTH TERRI LYNN13 citations91
US8268313B2Sep 18, 2012
Methods for using inhibitors of vascular endothelial growth factor activity
DAVIS-SMYTH TERRI LYNN1 citations61
US8268591B2Sep 18, 2012
Compositions and methods for producing inhibitors of vascular endothelial growth factor activity
DAVIS-SMYTH TERRI LYNN1 citations61